Clinical outcome of patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC) treated with pembrolizumab.

被引：3
|
作者：
Sinicrope, Frank A. [1 ]
Chakrabarti, Sakti [1 ]
Eiring, Rachel [1 ]
Mitchelll, Jessica L. [1 ]
Finnes, Heidi D. [1 ]
Hubbard, Joleen Marie [1 ]
McWilliams, Robert R. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e24127
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e24127
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Durable clinical benefit with nivolumab (NIVO) plus low-dose ipilimumab (IPI) as first-line therapy in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC)
    Lenz, H-J. J.
    Van Cutsem, E.
    Limon, M. L.
    Wong, K. Y.
    Hendlisz, A.
    Aglietta, M.
    Garcia-Alfonso, P.
    Neyns, B.
    Luppi, G.
    Cardin, D.
    Dragovich, T.
    Shah, U.
    Atasoy, A.
    Postema, R.
    Boyd, Z.
    Ledeine, J-M.
    Overman, M.
    Lonardi, S.
    ANNALS OF ONCOLOGY, 2018, 29 : 714 - 714
  • [32] Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) stage IV colorectal cancer (CRC)
    Andre, Thierry
    Sposetti, Caterina
    Gumus, Mahmut
    Ahn, Joong Bae
    Wyrwicz, Lucjan
    Kwiatkowski, Mariusz
    Kim, Jong Gwang
    Yalcin, Suayib
    Sendur, Mehmet A. N.
    Odeleye-Ajakaye, Amos
    Leconte, Pierre
    Fogelman, David R.
    Kim, Tae Won
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [33] Impact of microsatellite instability (MSI) on tumor clonal evolution in metastatic colorectal cancer (mCRC).
    Willis, Jason
    Morelli, Maria Pia
    Morris, Van Karlyle
    Loree, Jonathan
    Lam, Michael
    Pereira, Allan Andresson Lima
    Raghav, Kanwal Pratap Singh
    Kee, Bryan K.
    Sanchez, Eduardo Vilar
    Eng, Cathy
    Manuel, Shanequa
    Crosby, Shadarra
    Wolff, Robert A.
    Lanman, Richard B.
    Talasaz, AmirAli
    Janku, Filip
    Overman, Michael J.
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [34] Pancytopenia And Limbic Encephalopathy Complicating Immunotherapy For Clear Cell Endometrial Cancer With Microsatellite Instability-High (MSI-H)
    Kanbour, Aladdin
    Rasul, Kakil Ibrahim
    Albader, Salha Bujassoum
    Al Sulaiman, Reem Jawad
    Melikyan, Gayan
    Farghaly, Hanan
    Lengyel, Zsolt
    Al Rimawi, Yousef
    Soliman, Dina
    Omar, Nabil Elhadi
    ONCOTARGETS AND THERAPY, 2019, 12 : 9965 - 9973
  • [35] Analysis of candidate target genes for mononucleotide repeat mutation in microsatellite instability-high (MSI-H) endometrial cancer
    Kawaguchi, Makiko
    Banno, Kouji
    Yanokura, Megumi
    Kobayashi, Yusuke
    Kishimi, Arisa
    Ogawa, Seiji
    Kisu, Iori
    Nomura, Hiroyuki
    Hirasawa, Akira
    Susumu, Nobuyuki
    Aoki, Daisuke
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 35 (05) : 977 - 982
  • [36] Frequent inactivation of PTEN by promoter hypermethylation and its association with microsatellite instability-high (MSI-H) in sporadic colorectal cancers
    Goel, A
    Arnold, CN
    Niedzwieckl, D
    Carethers, JM
    Wasserman, L
    Compton, C
    Mayer, RJ
    Bertagnolli, MM
    Boland, CR
    GASTROENTEROLOGY, 2002, 122 (04) : A124 - A124
  • [37] Nivolumab plus ipilimumab combination in patients with DNA mismatch repair-deficient/microsatellite instability-high (dMMR/MSI-H) metastatic colorectal cancer (mCRC): First report of the full cohort from CheckMate-142.
    Andre, Thierry
    Lonardi, Sara
    Wong, Mark
    Lenz, Heinz-Josef
    Gelsomino, Fabio
    Aglietta, Massimo
    Morse, Michael
    Van Cutsem, Eric
    McDermott, Raymond S.
    Hill, Andrew G.
    Sawyer, Michael B.
    Hendlisz, Alain
    Neyns, Bart
    Svrcek, Magali
    Moss, Rebecca Anne
    Ledeine, Jean-Marie
    Cao, Z. Alexander
    Kamble, Shital
    Kopetz, Scott
    Overman, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [38] Microsatellite instability in metastatic colorectal cancer (mCRC)
    Kim, Jee Hung
    Kim, Chang-gon
    Ahn, Joong Bae
    Jung, MinKyu
    Beom, Seung Hoon
    Kim, Joo Hoon
    Heo, Soo Jin
    Shin, Sang Joon
    CANCER RESEARCH, 2016, 76
  • [39] Health-related quality of life (HRQoL) in patients (pts) treated with pembrolizumab (pembro) vs chemotherapy as first-line treatment in microsatellite instability-high (MSI-H) and/or deficient mismatch repair (dMMR) metastatic colorectal cancer (mCRC): Phase III KEYNOTE-177 study
    Andre, T.
    Amonkar, M.
    Norquist, J.
    Shiu, K-K.
    Kim, T. W.
    Jensen, B. V.
    Jensen, L. H.
    Punt, C. J.
    Smith, D.
    Garcia-Carbonero, R.
    Sevilla, I.
    de la Fouchardiere, C.
    Rivera, F.
    Elez, E.
    Diaz, L. A.
    Yoshino, T.
    Van Cutsem, E.
    Yang, P.
    Farooqui, M. Z. H.
    Le, D.
    ANNALS OF ONCOLOGY, 2020, 31 : S409 - S409
  • [40] Durable near complete remission induced by Pembrolizumab in a chemotherapy-refractory sporadic microsatellite instability-high [MSI-H] colon cancer patient: A call for liberal MSI testing
    Maerz, W.
    Hirschmann, M.
    Lodzinski, M.
    Rappel, S.
    Hartmann, A.
    Billet, F.
    Thomschke, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 275 - 275
12345